Reyes Joyce 4/A

4/A · Histogen Inc. · Filed Apr 28, 2023

Form 4/AAmended

Period: 2023-03-10

See Remarks

Transactions

Disposition to Issuer
Stock Option (right to buy)
2023-03-10−4,452→ 0 total
Exercise: $4.80Exp: 2032-02-17→ Common Stock (4,452 underlying)
Award
Stock Option (right to buy)
2023-03-10+47,417→ 47,417 total
Exercise: $0.95Exp: 2033-03-10→ Common Stock (47,417 underlying)
Award
Stock Option (right to buy)
2023-03-10+16,659→ 16,659 total
Exercise: $0.95Exp: 2033-03-10→ Common Stock (16,659 underlying)
Disposition to Issuer
Stock Option (right to buy)
2023-03-10−1,200→ 0 total
Exercise: $4.80Exp: 2032-02-17→ Common Stock (1,200 underlying)
Disposition to Issuer
Stock Option (right to buy)
2023-03-10−7,833→ 0 total
Exercise: $3.20Exp: 2032-06-01→ Common Stock (7,833 underlying)

Footnotes (7)

[F1]1/4 of the shares subject to the option vest one year after the date of grant, on 3/10/2024, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
[F2]The shares subject to this option are subject to forfeiture in the event that the shares available pursuant to the Plan are not increased prior to the one-year anniversary and vesting of the award by an amount required to be available for issuance for all outstanding stock awards containing this forfeiture condition.
[F3]Effective June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share.
[F4]On March 10, 2023, the Issuer and the Reporting Person agreed to cancel the stock option award.
[F5]1/4 of the shares subject to the option vested on 9/15/2022 and the remaining 1/36 of the shares vest on a monthly basis thereafter.
[F6]1/4 of the shares subject to the option vested on 11/8/2022 and the remaining 1/36 of the shares vest on a monthly basis thereafter.
[F7]1/4 of the shares subject to the option vest one year after the date of grant, on 6/1/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.

Documents

1 file